AGENDA
dubai, uae
11 October 2025
07:00 AM - 08:00 AM
REGISTRATION
WORKSHOPS
WORKSHOP-1
08:00 AM - 08:45 AM
RADIOLOGICAL BIOMARKERS IN MS
MODERATOR
tba
SPEAKER
tba
objectives:
- Identify key MRI features associated with disease activity, progression, & treatment response.
- Interpret radiological findings in the context of current diagnostic criteria, including the 2017 McDonald Criteria.
WORKSHOP-2
08:45 AM - 09:30 AM
Clinical Scale in MS Care
MODERATOR
tba
SPEAKER
tba
SPEAKER
tba
objectives:
- Explore the most commonly used clinical scales in MS, including EDSS, MSFC, and PROMs.
- Develop skills to accurately assess and document neurological disability and functional status.
- Integrate clinical scales into routine MS care to monitor disease progression and evaluate treatment efficacy.
09:30 AM - 09:50 AM
COFFEE BREAK
09:50 AM - 10:00 AM
WELCOME MESSAGE & INTRODUCTION
tba
tba
EXPANDING HORIZONS IN MS PATHOGENESIS
SESSION 1
moderators
MODERATOR
tba
SPEAKER
tba
SPEAKER
tba
10:00 AM - 10:20 AM
IMPACT OF EBV
tba
10:20 AM - 10:40 AM
GUT MICROBIOTA & MS
tba
10:40 AM - 11:00 AM
ROLE OF BIOMARKERS
tba
11:00 AM - 11:10 AM
CHALLENGE CASE 1
tba
11:10 AM - 11:25 PM
PANEL DISCUSSION
11:25 PM - 11:40 PM
Symposium 1
tba
11:40 AM - 11:55 AM
Symposium 2
tba
SHOULD ELDERLY PATIENTS WITH MS DISCONTINUE THERAPY?
DEBATE
moderators
MODERATOR
tba
SPEAKER
tba
SPEAKER
tba
11:55 AM - 12:05 PM
YES
tba
12:05 PM - 12:15 PM
NO
tba
12:15 PM - 12:20 PM
PANEL DISCUSSION
12:20 PM - 12:35 PM
Symposium 3
tba
12:35 PM - 12:50 PM
Symposium 4
tba
12:50 PM - 01:50 PM
LUNCH BREAK
ADVANCES IN MS TREATMENT
SESSION 2
moderators
MODERATOR
tba
SPEAKER
tba
SPEAKER
tba
01:50 PM - 02:10 PM
BTK INHIBITORS IN PROGRESSIVE MS
tba
02:10 PM - 02:30 PM
ADVANCES IN REMYELINATION THERAPIES
tba
02:30 PM - 02:50 PM
AHSC TRANSPLANTATION IN MS - UAE EXPERIENCE
tba
02:50 PM - 03:10 PM
DISCONTINUATION OF DMT
tba
03:10 PM - 03:20 PM
CHALLENGE CASE 2
tba
03:20 PM - 03:35 PM
PANEL DISCUSSION
MS CARE & CLINICAL PRACTICE
SESSION 3
moderators
MODERATOR
tba
SPEAKER
tba
SPEAKER
tba
03:35 PM - 03:55 PM
OPTIC NEURITIS APPROACH
tba
03:55PM - 04:15 PM
NMOSD & MOG
tba
04:15 PM 04:35 PM
NON-MS DEMYLINATING DISEASES IN PEDIATRIC
tba
04:35 PM 04:55 PM
SYMPTOMATIC TARGET APPROACH IN MS
tba
04:55 PM - 05:05 PM
CHALLENGE CASE 3